Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only

Jan J. Jobsen; Lambert Naudin ten Cate; Marnix L.M. Lybeert; Astrid Scholten; Elzbieta M. van der Steen-Banasik; Jacobus Adrianus Maria van der Palen; Marika C. Stenfert Kroese; Annerie Slot; Eltjo M. Schutter; Sabine Siesling

doi:10.1155/2011/962518

Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only

Jan J. Jobsen, Lambert Naudin ten Cate, Marnix L.M. Lybeert, Astrid Scholten, Elzbieta M. van der Steen-Banasik, Jacobus Adrianus Maria van der Palen, Marika C. Stenfert Kroese, Annerie Slot, Eltjo M. Schutter, Sabine Siesling

Faculty of Behavioural, Management and Social Sciences

Research output: Contribution to journal › Article › Academic › peer-review

105 Downloads (Pure)

Abstract

Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa

Original language	English
Pages (from-to)	962518-
Number of pages	7
Journal	Obstetrics and gynecology international
Volume	2011
DOIs	https://doi.org/10.1155/2011/962518
Publication status	Published - 2011

Keywords

IR-77985
METIS-282243

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1155/2011/962518

Endom_IIIA_one_siteFinal published version, 682 KB

Cite this

Jobsen, J. J., Naudin ten Cate, L., Lybeert, M. L. M., Scholten, A., van der Steen-Banasik, E. M., van der Palen, J. A. M., Stenfert Kroese, M. C., Slot, A., Schutter, E. M., & Siesling, S. (2011). Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only. Obstetrics and gynecology international, 2011, 962518-. https://doi.org/10.1155/2011/962518

@article{f0cbe6b881df4aca8032ef1a0e7d9f93,

title = "Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only",

abstract = "Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa",

keywords = "IR-77985, METIS-282243",

author = "Jobsen, {Jan J.} and {Naudin ten Cate}, Lambert and Lybeert, {Marnix L.M.} and Astrid Scholten and {van der Steen-Banasik}, {Elzbieta M.} and {van der Palen}, {Jacobus Adrianus Maria} and {Stenfert Kroese}, {Marika C.} and Annerie Slot and Schutter, {Eltjo M.} and Sabine Siesling",

note = "Open access article ",

year = "2011",

doi = "10.1155/2011/962518",

language = "English",

volume = "2011",

pages = "962518--",

journal = "Obstetrics and gynecology international",

issn = "1687-9589",

publisher = "Wiley",

}

TY - JOUR

T1 - Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only

AU - Jobsen, Jan J.

AU - Naudin ten Cate, Lambert

AU - Lybeert, Marnix L.M.

AU - Scholten, Astrid

AU - van der Steen-Banasik, Elzbieta M.

AU - van der Palen, Jacobus Adrianus Maria

AU - Stenfert Kroese, Marika C.

AU - Slot, Annerie

AU - Schutter, Eltjo M.

AU - Siesling, Sabine

N1 - Open access article

PY - 2011

Y1 - 2011

N2 - Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa

AB - Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa

KW - IR-77985

KW - METIS-282243

U2 - 10.1155/2011/962518

DO - 10.1155/2011/962518

M3 - Article

SN - 1687-9589

VL - 2011

SP - 962518-

JO - Obstetrics and gynecology international

JF - Obstetrics and gynecology international

ER -

Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this